APA (7th ed.) Citation

VT, H., HT, K., J, B., I, G., H, D., C, R., . . . RJ, S. (2022). GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: A randomized, double-blinded, phase 2 trial. Blood advances, 6(7), 2183. https://doi.org/10.1182/bloodadvances.2021006255

Chicago Style (17th ed.) Citation

VT, Ho, et al. "GM-CSF Secreting Leukemia Cell Vaccination for MDS/AML After Allogeneic HSCT: A Randomized, Double-blinded, Phase 2 Trial." Blood Advances 6, no. 7 (2022): 2183. https://doi.org/10.1182/bloodadvances.2021006255.

MLA (9th ed.) Citation

VT, Ho, et al. "GM-CSF Secreting Leukemia Cell Vaccination for MDS/AML After Allogeneic HSCT: A Randomized, Double-blinded, Phase 2 Trial." Blood Advances, vol. 6, no. 7, 2022, p. 2183, https://doi.org/10.1182/bloodadvances.2021006255.